Shenzhen Kangtai Biological Products Co., Ltd. (SHE:300601)

China flag China · Delayed Price · Currency is CNY
15.34
+0.09 (0.59%)
Feb 3, 2026, 1:25 PM CST
6.75%
Market Cap17.03B -5.9%
Revenue (ttm)2.70B -11.0%
Net Income-100.29M
EPS-0.08
Shares Out1.12B
PE Ration/a
Forward PE59.04
Dividend0.09 (0.58%)
Ex-Dividend DateJun 6, 2025
Volume7,377,832
Average Volume19,647,928
Open15.98
Previous Close15.25
Day's Range15.15 - 15.98
52-Week Range13.10 - 21.12
Beta0.94
RSI43.10
Earnings DateApr 22, 2026

About SHE:300601

Shenzhen Kangtai Biological Products Co., Ltd. researches and develops, produces, and sells various types of human vaccines in China. The company’s marketed vaccines include 13-valent pneumococcal polysaccharide conjugate vaccine, varicella vaccine, freeze-dried, hepatitis B vaccine, inflammatory vaccine, 23-valent pneumococcal polysaccharide vaccine, DTAP/HIB combined vaccine, diphtheria, tetanus and acellular pertussis combined vaccine, adsorbed, rabies vaccine (human diploid cell) for human use, hib conjugate vaccine, measles and rubella com... [Read more]

Sector Healthcare
Founded 1992
Employees 1,913
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300601
Full Company Profile

Financial Performance

In 2024, SHE:300601's revenue was 2.65 billion, a decrease of -23.75% compared to the previous year's 3.48 billion. Earnings were 201.65 million, a decrease of -76.59%.

Financial Statements